We have some major happenings around the site starting today.
In keeping with our tradition of writing tough, in-your-face articles, we're showcasing our investigative reporters -- and their talents for probing and hectoring -- by introducing an ongoing series of Special Reports.
offering -- by Adam Feuerstein -- appears on
now. During the past several months, Adam has followed
-- a small biotech company in Massachusetts -- and its impending launch of a blood substitute, Hemopure. Biotech companies usually need only six months to release late-stage safety data but Biopure has taken more than a year to finish its research on Hemopure.
What's going on at Biopure? Plenty. Adam, a financial journalist for 12 years, offers this: "Investors need to know more about Biopure than company executives are letting on."
Don't miss Adam's Special Report, which casts doubt on whether Hemopure will be coming out at all.
Our second big event debuts today.
And I mean big.
Ben Stein, the famed Hollywood actor and financial journalist, joins us to write "Reality Test," a weekly
column on the economy and markets that will appear every Wednesday morning.
Most of you know Ben as the cranky schoolteacher in
Ferris Bueller's Day Off
or as the star of his own game show -- "Win Ben Stein's Money" on
. Actually, that's where I met him, too. I interviewed him three years ago for a
New York Times
We've stayed in touch and Ben was excited about the opportunity to write for us.
What many of you don't know about Ben is that prior to his career as an actor, he was a columnist for
The Wall Street Journal
and a White House speechwriter for Presidents Richard Nixon and Gerald Ford.
Ben's one of the best financial journalists around, and I'm proud to have him writing for us. Ben's first four columns will appear on
, our flagship site, and
, our premium site. But after that, Ben's articles will appear only on
David Morrow is editor-in-chief of TheStreet.com. In keeping with TSC's editorial policy, he doesn't own or short individual stocks, though he owns stock in TheStreet.com. He also doesn't invest in hedge funds or other private investment partnerships. He welcomes your feedback and invites you to send it to